Rare Digenic Variants Link Neuroinflammation and Gut Dysbiosis in Parkinson’s Disease
A rare digenic combination of LRRK2 and MAPT variants drives dopaminergic neurodegeneration, interferon-mediated neuroinflammation, and gut microbiota dysbiosis in Parkinson's ...

